This trial is active, not recruiting.

Condition macular degeneration
Treatment retisert implant
Phase phase 2
Sponsor Control Delivery Systems
Collaborator Bausch & Lomb Incorporated
Start date November 2001
Trial identifier NCT00032396, CDS FL-004


A study evaluating Retisert in patients with age-related macular degeneration

United States No locations recruiting
Other countries No locations recruiting

Study Design

Primary purpose treatment

Eligibility Criteria

Male or female participants at least 55 years old.

Trial information was received from ClinicalTrials.gov and was last updated in May 2006.
Information provided to ClinicalTrials.gov by Control Delivery Systems.